RSS   Newsletter   Contact   Advertise with us
Post Online Media

Sangamo Therapeutics appoints Kathy Yi as CFO

Sangamo TherapeuticsSangamo Therapeutics, a biotechnology company, announced the appointment of Kathy Yi as senior vice president and chief financial officer.

Ms. Yi most recently served as Head of Finance for Novartis Pharmaceuticals' Global Inhalation Technical Research & Development group, responsible for the financial management of technical R&D organizations in California and Switzerland.

Prior to Novartis, Ms. Yi held financial management positions of increasing seniority at Life Technologies Corp., from 2007 to 2014, including Finance Leader, Corporate FP&A.

Earlier, she held various positions in finance at Intel Corp, from 2001 to 2007.

Ms. Yi received a B.S. in Chemical Engineering from University of California, Berkeley, and an M.B.A. from Columbia Business School.


More inside POST

We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy